1. 153OM7824 (MSB0011359C), a bifunctional fusion protein targeting transforming growth factor β (TGF-β) and PD-L1, in Asian patients with pretreated biliary tract cancer (BTC): Efficacy by BTC subtype. (25th November 2018) Authors: Yoo, C; Oh, D-Y; Choi, H J; Kudo, M; Ueno, M; Kondo, S; Chen, L-T; Osada, M; Helwig, C; Dussault, I; Ikeda, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 661PUpdated results from a phase I trial of M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients with pretreated recurrent or refractory gastric cancer. (23rd October 2018) Authors: Bang, Y-J; Doi, T; Kondo, S; Chung, H C; Muro, K; Dussault, I; Helwig, C; Osada, M; Kang, Y-K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 757PM7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in Asian patients with pretreated biliary tract cancer: Preliminary results from a phase I trial. (23rd October 2018) Authors: Yoo, C; Oh, D-Y; Choi, H J; Kudo, M; Ueno, M; Kondo, S; Chen, L-T; Osada, M; Helwig, C; Dussault, I; Ikeda, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Experimental study of frictional resistance influences on tunnel face stability. Issue 1 (1st January 2023) Authors: Kawanoue, R; Yagihashi, T; Togashi, Y; Osada, M Journal: IOP conference series Issue: Volume 1124:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗